Skip to main content

Counts and Characteristics of Long-Acting Injectable Antipsychotic (LAIA) Users: A Descriptive Analysis

    Basic Details
    Date Posted
    Medical Product
    long-acting injectable antipsychotics

    In this report we examined counts of individuals exposed to long-acting injectable antipsychotics (LAIA) in the Sentinel Distributed Database (SDD) and described demographic, health and treatment characteristics of these individuals.

    The study period includes data from January 1, 2010 to December 31, 2021. We distributed this request to one Sentinel Data Partner on September 27, 2022. 

    Additional Details
    FDA Center
    Time Period
    January 1, 2010 – December 31, 2021
    Analysis Type
    Population / Cohort
    Individuals 18 years of age and older
    Data Sources
    Sentinel Distributed Database (SDD)